ACP
AGN

Aviance Capital Partners’s Allergan plc AGN Stock Holding History

Aviance Capital Partners’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-118,957
Closed -$21.1M – 244
2020
Q1 		$21.1M Sell
118,957
-25
-0% -$4.71K 6.64% 2
2019
Q4 		$22.7M Hold
118,982
– – 5.82% 2
2019
Q3 		$20M Sell
118,982
-315
-0.3% -$51.3K 5.88% 2
2019
Q2 		$20M Sell
119,297
-100
-0.1% -$13.8K 5.51% 2
2019
Q1 		$17.5M Sell
119,397
-190
-0.2% -$27.5K 5.01% 3
2018
Q4 		$16M Sell
119,587
-68,402
-36% -$11.2M 5.62% 2
2018
Q3 		$35.8M Buy
187,989
+67,967
+57% +$12.5M 8.64% 2
2018
Q2 		$20M Sell
120,022
-172
-0.1% -$27.6K 5.79% 2
2018
Q1 		$20.2M Sell
120,194
-869
-0.7% -$146K 6.1% 2
2017
Q4 		$19.8M Sell
121,063
-822
-0.7% -$148K 6.53% 2
2017
Q3 		$25M Sell
121,885
-642
-0.5% -$149K 8.45% 2
2017
Q2 		$29.8M Buy
122,527
+67,811
+124% +$15.9M 9.59% 1
2017
Q1 		$13.1M Sell
54,716
-68,824
-56% -$16M 4.77% 2
2016
Q4 		$25.9M Sell
123,540
-2,064
-2% -$428K 9.15% 1
2016
Q3 		$28.9M Sell
125,604
-597
-0.5% -$146K 10.22% 1
2016
Q2 		$29.2M Buy
126,201
+2,127
+2% +$490K 10.74% 1
2016
Q1 		$33.3M Sell
124,074
-760
-0.6% -$218K 11.57% 2
2015
Q4 		$39M Sell
124,834
-38
-0% -$11.3K 13.4% 1
2015
Q3 		$33.9M Buy
124,872
+487
+0.4% +$150K 13.94% 1
2015
Q2 		$37.7M Buy
124,385
+615
+0.5% +$183K 14.12% 1
2015
Q1 		$36.8M Sell
123,770
-10
-0% -$2.85K 13.5% 1
2014
Q4 		$31.9M Buy
123,780
+1,590
+1% +$397K 11.9% 1
2014
Q3 		$29.5M Buy
122,190
+120,415
+6,784% +$26.9M 11.15% 1
2014
Q2 		$396K Buy
+1,775
New +$368K 0.15% 168

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Aviance Capital Partners's AGN Position: Q2 2020 in Review

Aviance Capital Partners sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 118,957 shares — an estimated $21.1M sold.

Aviance Capital Partners first reported a position in AGN in Q2 2014 and held it in 24 quarters. The position peaked at $39M in Q4 2015. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Aviance Capital Partners reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Aviance Capital Partners sold 118,957 Allergan plc shares in Q2 2020, an estimated $21.1M.
  • Aviance Capital Partners first reported a position in Allergan plc in Q2 2014 and held it in 24 quarters.
  • Aviance Capital Partners's Allergan plc position peaked at $39M in Q4 2015.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Aviance Capital Partners's 13F filing for Q2 2020, filed 24 Jul 2020.